Evidence map›Paper›PMID 37159510›Full record

ArticleeLife2023

Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.

Romain Coppée, François Blanquart, Aude Jary, Valentin Leducq, Valentine Marie Ferré, Anna Maria Franco Yusti, Léna Daniel, Charlotte Charpentier, Samuel Lebourgeois, Karen Zafilaza and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Romain CoppéeUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.ORCID 0000-0002-3024-5928
François BlanquartUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.ORCID 0000-0003-0591-2466
Aude JarySorbonne Université, Inserm, iPLESP, Paris, France.
Valentin LeducqSorbonne Université, Inserm, iPLESP, Paris, France.
Valentine Marie FerréUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Anna Maria Franco YustiUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Léna DanielUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Charlotte CharpentierUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Samuel LebourgeoisUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Karen ZafilazaSorbonne Université, Inserm, iPLESP, Paris, France.
Vincent CalvezSorbonne Université, Inserm, iPLESP, Paris, France.
Diane DescampsUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Anne-Geneviève MarcelinSorbonne Université, Inserm, iPLESP, Paris, France.
Benoit VisseauxUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Antoine Bridier-NahmiasUniversité Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.ORCID 0000-0002-0376-6840
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although France was one of the most affected European countries by the COVID-19 pandemic in 2020, the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) movement within France, but also involving France in Europe and in the world, remain only partially characterized in this timeframe. Here, we analyzed GISAID deposited sequences from January 1 to December 31, 2020 (

Indexed as

COVID-19SARS-CoV-2EuropeFranceHumansPandemicsPhylogenyCOVID-19epidemiologyevolutionary biologyFrancegenomic epidemiologyglobal healthmaximum likelihoodphylodynamicsSARS-CoV-2viruses

Identifiers

PMID37159510
PMCPMC10179682
OpenAlexW4367055772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.